Humulin 30/70 is a premixed combination of 30% regular (short-acting) human insulin and 70% NPH (insulin isophane, intermediate-acting). This medicine is produced using recombinant DNA technology, making it identical to natural human insulin. The active ingredients provide precise dosing that begins to act quickly and maintains blood sugar control for up to 16–18 hours.

Using this dual-action formulation reduces the need for separate injections of short- and intermediate-acting insulin products, simplifying insulin therapy for patients who require both. It also helps minimize fluctuations in blood glucose levels and supports predictable absorption.

On our website, Humulin 30/70 vials are available in a 10 mL vial format for use with syringes.